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Abstract   
This chapter reviews the present state of knowledge on the activity of enzymes that 
function with the RNA exosome in the nucleus.  In this compartment, the exosome 
interacts physically and functionally with the exoribonuclease Rrp6 and several co-
factors, most prominently Rrp47 and the TRAMP complex.  These interactions decide the 
fate of RNA precursors from transcription through the formation of mature 
ribonucleoprotein particles (RNPs) and the export of the RNPs to the cytoplasm.  The 
nuclear exosome catalyzes the formation of the mature 3’ ends of many of these RNAs, 
but in other cases degrades the RNAs to mononucleotides.  Co-factors such as Mpp6, 
TRAMP and the Nrd1/Nab3 complex play important roles in determining the outcome of 
the interaction of RNPs with the nuclear exosome.  The details that govern the specificity 
of these decisions remain a rich source for future investigation. 
 
 4 
Introduction 
The RNA exosome plays an essential role in the processing and degradation of RNAs in 
eukaryotic organisms.  In the nucleus and the cytoplasm the nine-subunit exosome core, 
Exo9, and the ribonuclease Dis3/Rrp44 function as a unit, designated Exo10.  In 
Saccharomyces cerevisiae this complex interacts physically and functionally with a 
nucleus specific enzyme, Rrp6, to form the nuclear exosome, Exo11.  While the majority 
of Rrp6 resides in the nucleus in S. cerevisiae, evidence suggests its presence in the 
cytoplasm in humans, T. brucei and A. thaliana.
1-3
  In S. cerevisiae, where Rrp6 has been 
studied most extensively, deletion of the sole copy of its gene (RRP6) causes a slow 
growth phenotype at 30
o
C and extremely poor growth at 37
o
C.
4
  Nevertheless, the fact 
that deletion of any of the other exosome genes causes lethality has made the use of rrp6-
∆ strains a valuable tool for the study of exosome defects in nuclear RNA processing.  
These studies revealed a critical role for Rrp6 in maturation and degradation pathways 
that include all known classes of RNA.  The targeting of Rrp6 and Exo10 to these 
different RNA processing pathways is specified by interactions with protein co-factors 
such as Rrp47, Mpp6 and the TRAMP complex.  Moreover, studies in rrp6 mutants, or 
cells depleted of Rrp6, uncovered the existence of RNA polymerase II transcripts from 
virtually every part of the genomes of organisms as divergent as yeast, plants and 
humans.  These revelations along with evidence that Rrp6 regulates the levels of specific 
mRNAs indicate that the nuclear exosome and it co-factors may have key functions in the 
control of gene expression and organismal development.   
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Structure and activity of Rrp6 
Rrp6 belongs to the RNaseD family of the DEDD superfamily of exoribonucleases, 
which use a two-metal ion mechanism for RNA hydrolysis (Figure 1).
5
  Structure-
function studies of Rrp6 proteins with point mutations in the exonuclease domain 
confirmed the two-metal ion mechanism and suggested that, like the exonuclease 
domains of DNA polymerases, Rrp6 utilizes a phenylalanine to stabilize the hydroxyl 
anion intermediate activated for phosphodiester bond cleavage.
6, 7
  Unlike Dis3/Rrp44, 
whose activity is attenuated by interaction with Exo9, Rrp6 retains its characteristic 
properties in the Exo11 complex.
8
  Rrp6 contains two HRDC (Helicase RNaseD C-
terminal) domains, only one of which was predicated by sequence homology.  The Rrp6 
HRDC1 domain folds into a characteristic 5-helix structure nearly identical to the 
homologous portion of E. coli RNaseD (Figure 1).
7, 9
  Surprisingly, a second HRDC 
domain appears directly after this in the RNaseD structure, despite a paucity of sequence 
similarity to HRDC1 or other HRDC domains.  Although the polypeptide used for crystal 
structure analysis of S. cerevisiae Rrp6 did not carry HRDC2, it seems reasonable to 
believe that this region folds to create a similar structure in eukaryotes.  Comparison of 
the activities of S. cerevisiae Rrp6 derivatives deleted for either HRDC1 or HRDC2 
indicated that HRDC2 plays a critical role in the ability of the protein to interact with 
Exo10 in vivo.
10
  Rrp6 deleted for HRDC2, but not HRDC1, carries out RNA 3’ end 
processing of pre-snoRNAs and pre-5.8S rRNA (see below), but fails to degrade certain 
rRNA intermediates that require co-operation between the activities of Rrp6 and 
Dis3/Rrp44.  Thus, the HRDC2 domain appears to facilitate protein-protein interaction 
between Rrp6 and Exo10.  Rrp6 and its eukaryotic homologues carry an N-terminal 
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region (PMC2NT) not found in bacteria.  This region is dispensable for interaction with 
Exo10, but is necessary and sufficient for binding to the Rrp6 co-factor Rrp47/Lrp1 (C1D 
in humans; see below).
11
  Thus, for RNA 3’ end maturation reactions the interaction of 
Rrp6 with Rrp47 appears more important than the ability of Rrp6 to bind Exo10. 
 
The role of Rrp6 in the maturation of non-coding RNAs 
Early studies showed that Rrp6 plays a critical role in the maturation of 5.8S pre-RNA.
4
  
Rrp6 catalyzes the 3’ end trimming of 5.8S pre-rRNA from its 5.8S+30 form to the 6S 
form, whose end is trimmed to the mature 5.8S rRNA by cytoplasmic Ngl2.
4, 12
  Rrp6 
requires Rrp47/Lrp1 in budding yeast, or its homologue C1D in humans, for efficient 
trimming of 3’ extended 5.8S precursors.11, 13, 14  The 5.8S+30 pre-RNA substrate results 
from 3’-5’ processing by Exo10 of a longer precursor, 7S pre-rRNA, generated by 
cleavage at the C2 site with the pre-rRNA internal transcribed spacer.
15
  Thus, generation 
of 6S pre-rRNA in the nucleus requires the concerted 3’-5’ exoribonuclease activities of 
Dis3/Rrp44 (in the context of Exo10) and Rrp6, suggesting that the Exo11 complex 
converts 7S to 6S pre-rRNA.  However, a mutation that disrupts the interaction between 
Rrp6 and Exo10 in vivo has no apparent effect on the conversion of 5.8S+30 pre-RNA to 
6S pre-rRNA, indicating physical independence of Rrp6 and Exo10 in this step.
10
 
 
Likewise, Rrp6 and Exo10 carry out stepwise 3’ end formation of sno-RNAs and sn-
RNAs precursors.
16, 17
  The independently transcribed sno-RNAs and some of the sn-
RNAs are synthesized as 3’ extended precursors that are trimmed in the 3’-5’ direction by 
Exo10, followed by removal of the last few nucleotides by Rrp6.  Like the processing of 
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7S pre-rRNA to 6S pre-rRNA, the last step, catalyzed by Rrp6, occurs efficiently in an 
Rrp6 mutant defective for interaction with Exo10, but requires interaction with Rrp47 via 
the Rrp6 PMC2NT domain.
11, 18
  Several studies suggest that some portion of mature 
snoRNAs results from the 3’ trimming of extended, polyadenylated forms of snoRNAs 
precursors, as opposed to their total degradation by an exosome catalyzed surveillance 
mechanism.
19-21
  This raises a longstanding question of how Rrp6 and Exo10 recognize 
which RNA substrates should be destroyed and which should be trimmed to their normal 
3’ ends.  Presumably, the answer depends on whether the RNAs have the combined RNA 
and protein structural information to keep the RNPs in a productive biogenesis pathway. 
 
The role of Rrp6 in mRNA surveillance 
Rrp6 was discovered by virtue of the fact that loss of function mutations suppress the 
temperature sensitive growth phenotype of a S. cerevisiae strain carrying a mutation 
(pap1-1) in the gene encoding the canonical mRNA poly(A)-polymerase Pap1.
4
  
Interestingly, loss of Rrp6 activity allowed the accumulation of poly(A)+ mRNAs under 
conditions where partial inactivation of Pap1 otherwise resulted in the disappearance of 
most mRNAs.
22
  Localization of Rrp6 to the nucleus, demonstration of its hydrolytic 
exoribonuclease activity and the fact that loss of its activity allowed accumulation of 
poly(A)+ mRNAs in pap1-1 strains without changing the rate limiting step in mRNA 
decay lead to the proposal that the enzyme plays a role in a nuclear mRNA surveillance 
pathway.
22
  Indeed, loss of Rrp6 activity reverses the disappearance of mRNAs caused by 
defects in other components of the mRNA 3’ end formation pathway, as well as cis-
acting defects that inhibit polyadenylation.
23-25
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The role of Rrp6 in nuclear mRNA surveillance includes an interesting, but poorly 
understood function in the accumulation of incompletely processed mRNAs at, or near, 
their site of transcription.
26
  Retention of specific transcripts in single nuclear foci in 
budding yeast occurs as a result of defects in 3’ end processing, or defects in the 
formation of export competent RNPs.
27
  Strains lacking Rrp6 fail to form these foci and 
the transcripts exit the nucleus.  These observations suggest that, in addition to its role in 
degrading aberrant transcripts, the presence of Rrp6 slows the transition of pre-mRNAs 
to export competent RNPs.  Indeed, defects in components of the THO/Sub2 complex, 
which bridges posttranscriptional events with mRNA export, result in mRNA degradation 
and Rrp6-dependent retention of pre-mRNAs in nuclear foci.
27-29
  The mechanistic details 
of the connection between the THO/Sub2 complex and the nuclear exosome remain 
unclear, but recent evidence suggests that THO/Sub2 defects inhibit the activity of the 
mRNA 3’ end processing machinery.29, 30  One interpretation of these findings is that 
disruption of the transition from pre-mRNA to an export competent RNP may feedback 
to down regulate mRNA 3’ end processing, thereby exposing transcripts to degradation 
by Exo11. 
 
Defects in Rrp6 and other exosome components render yeast and human cells 
hypersensitive to the chemotherapeutic drug 5-fluorouracil (5FU).
31-33
  This effect; (i) 
results from incorporation of the base analogue into RNA, (ii) is abolished by a mutation 
in Rrp6 that inhibits its degradation, but not by one that inhibits its 3’ end maturation 
function, (iii) correlates with the accumulation of poly(A)+ RNA degradation 
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intermediates and (iv) is independent of the transcription-coupled DNA repair pathway.
32, 
34
  Moreover, hypersensitivity of rrp6-∆ strains to 5FU requires a catalytically active 
pseudouridine synthetase, Cbf5.
35
  Some pseudouridine synthetases cannot convert 5FU 
into psuedouridine and the incomplete enzymatic reaction results in covalent adducts 
between the enzyme and 5FU-RNA.  These findings suggest that a significant component 
of 5FU cytotoxicity in S. cerevisiae may result from the inability of Rrp6 to degrade 
RNA molecules trapped in complexes with Cbf5. 
 
The role of Rrp6 in the regulation of mRNA levels 
Rrp6 controls the levels of normal mRNAs as exemplified by the autoregulation of the 
nuclear poly(A)-binding protein Nab2 activity in budding yeast.
36
  The interaction of 
Nab2 with an oligoadenylate sequence in the 3’ UTR of its own mRNA destabilizes the 
transcript in a manner dependent on Rrp6 activity.  Interestingly, NAB2 mRNA 3’ end 
formation occurs by a non-canonical mechanism that requires Exo10 and the Trf4 
component of the TRAMP complex.
37
  A similar mechanism forms the mature end of the 
CTH2 mRNA and, possibly other mRNAs.
38
  Rrp6 and the TRAMP complex regulate the 
levels of histone mRNAs by degrading the transcripts and contributing to their removal at 
the end of the S-phase of the cell cycle.  The requirement for Rrp6 suggests that the 
negative effect of histone synthesis beyond the end of S-phase requires the rapid 
destruction of their mRNAs in the nucleus as well as in the cytoplasm.
39, 40
  In Drosophila 
melanogaster, depletion of Rrp6 leads to mitotic defects that may reflect altered 
accumulation of mitotic mRNAs.
41
  Similarly, loss of Rrp6 activity causes meiotic 
defects in Schizosaccharomyces pombe, and evidence suggests that the Mmi protein 
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targets meiosis-specific pre-mRNAs for degradation by Rrp6.
42, 43
  Rrp6 also participates 
in a pathway that degrades mRNAs that exit the nucleus slowly; either due to defects in 
nuclear export, or naturally slow, mRNA-specific export rates.
44
  In this pathway, called 
DRN (Degradation of RNA in the Nucleus), Rrp6 acts in concert with the nuclear RNA 
cap-binding complex to accelerate the degradation of slowly exported mRNAs.
25
  These 
findings indicate that cells utilize the nuclear mRNA surveillance function of Rrp6 and 
perhaps Exo11 to regulate the concentration of a number of mRNAs for the purposes of 
simple feedback control and more complex regulation of cell cycle events.  It seems 
likely that the list of mRNAs whose levels are subject to regulation by Rrp6 and the 
exosome will continue to grow.  
 
Rrp6 and the TRAMP complex 
The surprising discovery of polyadenylated non-coding RNAs and the existence of non-
canonical poly(A)-polymerases revealed a role for Rrp6 and Exo10 in a polyadenylation 
dependent pathway for the degradation of aberrant RNA processing intermediates and 
transcripts arising from pervasive transcription of the genome.  The first clues to the 
existence of this pathway came from experiments that demonstrated the accumulation of 
polyadenylated sn- and snoRNAs, and pre-rRNAs in budding yeast strains lacking 
Rrp6.
16, 17, 45
  A key experiment also revealed that the degradation of hypomodified pre-
tRNAi
Met
 requires the activity of Dis3/Rrp44 and Rrp6.
46
  Importantly, these studies 
identified a requirement for the activity of the non-canonical poly(A)-polymerase Trf4 in 
destruction of the aberrant pre-tRNAi
Met
.  Later studies showed that Trf4 and another 
non-canonical poly(A)-polymerase, Trf5, exist in complexes with putative RNA-binding 
 11 
proteins Air1 and Air2, as well as with the RNA helicase Mtr4.
47, 48
  These complexes, 
called TRAMP4 and TRAMP5 respectively, play an essential role in the degradation of 
non-coding RNAs in eukaryotes.
49-51
  In some cases, these transcripts may arise from 
pervasive transcription of the genome that produces a surprising array of sense, antisense 
and intergenic transcripts, in addition to gene-encoding RNAs.
52-54
  Many of these RNAs, 
as well as intermediates in the biogenesis pathways producing sn-/snRNAs and rRNAs, 
are polyadenylated by the TRAMP complexes, which facilitates their hydrolysis by Rrp6 
and Exo10.   
 
This surveillance mechanism ensures the destruction of aberrant RNA processing 
intermediates and disposes of transcripts that result from pervasive bi-directional 
transcription initiation by RNA polymerase II.
55, 56
  While some of the RNAs generated in 
this manner appear to lack any function, evidence from budding yeast and Arabidopsis 
thaliana suggests that some influence gene regulation, development and gene silencing.
57-
60
  Experiments in S. pombe revealed a requirement for TRAMP and Rrp6 in the 
degradation of transcripts arising from silenced heterochromatin and in 
posttranscriptional control of RNAi-dependent gene silencing.
61-63
  TRAMP complexes 
likely play a critical role in determining the levels of these regulatory transcripts, since 
polyadenylation by TRAMP enhances RNA degradation by the nuclear exosome.  
However, how TRAMP distinguishes between RNAs destined for rapid turnover and 
other stable RNAs remains a major unanswered question. 
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The exosome cofactor Rrp47 
The yeast protein Rrp47 (also known as Lrp1 or yC1D) and its mammalian homologue 
C1D are eukaryotic, nuclear proteins that bind both RNA and DNA.
11, 14, 64, 65
 Research 
on Rrp47 has focussed on its physical association with the exosome nuclease complex.
13, 
66, 67
 and the role of this complex in RNA processing and degradation pathways (for 
recent reviews of exosome structure and function, see 
52, 68-71
), while C1D was initially 
characterised as a DNA-binding protein that functions in transcription and DNA repair.
64, 
72, 73
 Nevertheless, there is strong evidence of functional conservation of Rrp47/C1D; 
both proteins interact directly with the catalytic exosome component Rrp6 (known as 
PM-Scl100 in humans),
11, 14
 yeast rrp47-∆ mutants show defects in DNA repair74, 75 and 
similar defects on 5.8S rRNA maturation are observed in yeast rrp47-∆ and rrp6-∆ 
mutants and upon depletion of C1D in mammalian cells.
4, 13, 14
 
 
Structure of Rrp47 
Rrp47 and C1D are small, basic proteins of 21kDa and 16kDa, respectively. There is no 
detailed structural data currently available for these proteins but sequence homology and 
secondary structure prediction programmes
76
 suggest that the first ~120 amino acid 
residues of Rrp47 comprise a conserved N-terminal -helical domain, while the C-
terminal region is less structured and more variable. The C-terminus of Rrp47 and 
homologous proteins is rich in basic residues and presumably contributes to RNA 
binding.
11, 77
 Rrp47 and C1D can both be phosphorylated in vitro
73, 78
 but the functional 
relevance of this is not clear. In contrast to other exosome proteins including Rrp6, Rrp47 
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has not been observed as a phosphoprotein in mass spectrometric analyses of exosome 
complexes
79, 80
 or in orthophosphate in vivo labeling experiments (our unpublished data). 
 
The conserved N-terminal region of Rrp47/C1D spans the bioinformatically defined 
Sas10/C1D domain (residues 10-89 of Rrp47) 
81
 also present in Sas10 (also known as 
Utp3) and Lcp5, two U3 small nucleolar RNA (snoRNA)-associated proteins that are 
components of the small subunit processosome or pre-90S subunit.
82-86
 Overexpression of 
Sas10 partially suppressed silencing of transcriptionally repressed chromatin in a Sir-
independent manner,
87
 an effect that has also been reported for mutants in the exosome 
and TRAMP complexes.
88, 89
 One possibility is that overexpression of Sas10 may 
(partially) titrate out the complex between Rrp47 and Rrp6. A Sas10/C1D domain is also 
found in the protein neuroguidin, an eIF4E-binding protein that is required for 
cytoplasmic polyadenylation-dependent translational control in neuronal cells.
90
 Sas10, 
Lcp5 and neuroguidin also have basic regions at their C-termini that may contribute to 
RNA binding but whether the Sas10/C1D domain represents an RNA-binding domain 
requires further experimentation. 
 
Biochemical activities of Rrp47 
Rrp47 and C1D are associated with Rrp6-containing exosome complexes
13, 67
 and interact 
directly with Rrp6 in vitro.
11, 14
 Binding occurs via the N-terminal PMC2NT domain of 
Rrp6
91
 and the N-terminal -helical region of Rrp47 (our unpublished observations). 
Westerns of epitope-tagged proteins show that Rrp47 and Rrp6 are expressed at 
comparable levels in yeast,
11
 Rrp6 being present at approximately 2,000 molecules per 
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cell.
92
 Normal expression levels of Rrp47 in yeast are dependent upon this interaction 
with Rrp6.
11
 Therefore, the interpretation of data from experiments using rrp6-∆ null 
alleles should take into account that Rrp47 expression levels are also significantly 
affected. 
 
Rrp47 and C1D show specificity for structured RNA in vitro.
11, 14
 Consistent with an 
important role for Rrp47 RNA binding activity in vivo, RNAs that accumulate in rrp47-∆ 
mutants, such as the 3’ extended 5.8S rRNA precursor, are predicted to have double 
stranded regions at their 3’ termini.93 The dissociation constant of yeast Rrp47 for RNA 
and DNA is approximately 1M (calculating the protein concentration based on the 
predicted molecular weight of the monomeric protein).
11
 C1D is reported to have 
“exceptional DNA affinity”64 but the dissociation constant for DNA or RNA has not been 
reported and it is not clear whether the native protein has a preference for DNA or RNA 
substrates. Assuming there are approximately 2,000 molecules of Rrp47 per yeast cell 
and the protein is distributed evenly throughout the nucleus, which has a volume of 
approximately 3m,94 the intracellular concentration of Rrp47 is close to its dissociation 
constant. Therefore, small regulatory changes in the effective concentration of Rrp47 
would impact strongly on the efficiency with which this protein would bind its target 
substrates. Notably, overexpression of C1D is toxic.
95
 
 
The Role of Rrp47 in RNA Processing and Degradation 
Yeast strains lacking Rrp47 or Rrp6 accumulate a common set of cellular RNAs that, in 
wild-type cells, are normally efficiently processed to mature RNAs or rapidly degraded. 
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Rrp47 is not required for normal Rrp6 expression levels or the association of Rrp6 with 
exosome complexes.
13
 Since a trimeric complex can be formed between Rrp47, Rrp6 and 
RNA, it has been suggested that Rrp47 promotes substrate binding to Rrp6.
11
 Purified 
Rrp6 degrades unstructured RNA efficiently but is blocked by stem loop structures,
8, 22
 
suggesting that Rrp47 may facilitate degradation of structured RNA. Rrp47/C1D does not 
have any sequence homology to RNA helicases. Rrp47 might simply increase the 
retention time of Rrp6 on structured substrates or it may function sterically by positioning 
the 3’ end of structured RNA close to the catalytic centre of Rrp6, as has been proposed 
for the C’-terminal HRDC domain of RNase D.9 Notably, while the pattern of stable 
RNA precursors observed in rrp47-∆ and rrp6-∆ strains by northern blot analyses are 
largely indistinguishable,
13
 distinct effects are seen in these mutants upon analysis of 
global mRNA profiles.
75, 96
 This suggests that Rrp6 can function independently of Rrp47 
on some substrates. 
 
Rrp47 might also function in substrate recognition, either through interaction with RNA 
or other processing factors (Figure 2). Interactions between the Nrd1 termination 
complex and the exosome and TRAMP complexes are thought to recruit the 
degradation/processing machinery to some of its RNA substrates
97
 and Rrp47 is present 
in such large RNA processing/degradation complexes.
98
 Nrd1 and the associated protein 
Nab3 are RNA-binding proteins that bind cooperatively to multiple copies of tetrameric 
recognition sequences present in the terminator regions of target transcripts.
99
 The rrp47-
∆ mutation is synthetic lethal with the RNA-binding defective nrd1-102 mutation,100 
suggesting that the RNA-binding activity of Rrp47 may play an important role in the 
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recruitment of the exosome to the termination complex. It has also been suggested that 
the interaction between Rrp47 and DNA may help position exosome complexes at 
transcriptionally active sites.
101
 
 
Rrp47/C1D is well annotated as a DNA repair factor. Yeast strains lacking Rrp47 or Rrp6 
are defective in the degradation of specific mRNA transcripts upon exposure to UV 
irradiation and in the repair of UV irradiation-induced cyclobutane dimers, and rrp6-∆ 
mutants are synergistically sick in combination with rad26-∆ mutants.75 The sensitivity 
of rrp6-∆ and rrp47-∆ mutants to UV irradiation may reflect a quality control function of 
the exosome to eliminate aberrant transcripts that arise as a result of DNA damage in 
transcription-coupled DNA repair.
102
 
 
The exosome cofactor Mpp6 
Mpp6 (MPP6 in humans) shares a number of similarities with Rrp47, both being 
exosome-associated RNA-binding proteins that are small and basic in nature. The 
proteins have distinct substrate specificities, however, Rrp47 recognising structured RNA 
while Mpp6 binds pyrimidine-rich sequences.
11, 14, 98, 103
 While Rrp47 is functionally 
linked to the activity of Rrp6, the role of Mpp6 in exosome function is less clear. 
 
MPP6 was first identified as a nuclear protein that is phosphorylated and distributed 
throughout the cell during mitosis.
104
 MPP6 copurifies with exosome complexes that 
contain the Rrp6 homologue PM-Scl100 and hMtr4 but which lack the Rrp44/Dis3 
homologue.
105
 Thus, the interaction between MPP6 and the exosome is independent of 
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Rrp44. Interactions between MPP6 and PM-Scl100 or hMtr4 were first suggested by two-
hybrid interaction
106
 and subsequently shown to be direct by pull-down experiments 
using recombinant and in vitro translated proteins.
14
 The binding sites within Rrp6 for 
MPP6 and C1D apparently do not overlap, since a stable trimeric complex could be 
assembled. 
 
Depletion of MPP6 caused an accumulation of 3’ extended forms of 5.8S rRNA similar 
to that seen upon loss of exosome function.
103
 Notably, the 3’ extended 5.8S pre-rRNA 
that accumulates upon depletion of MPP6 contains a pyrimidine-rich sequence at its 3’ 
end, suggesting that MPP6 might target the exosome to this substrate. Consistent with a 
role in pre-rRNA processing, both the mammalian and yeast proteins are found 
associated with large ribosome-containing complexes.
103, 107
 
 
The yeast protein Mpp6 was first demonstrated to be associated with the exosome 
complex in a global proteomics study
86
 and subsequently shown to be required for 
viability of rrp47-∆ mutants.98 In common with other exosome mutants, mpp6-∆ strains 
showed defects in 5.8S rRNA maturation, accumulated the IGS1-R rDNA intergenic 
transcript and suppressed the loss of mRNA observed in rna14-1 and prp2-1 strains.
23, 88, 
89, 98, 108
 Notably, the accumulation of the NEL025C CUT upon loss of both Mpp6 and 
Rrp47 was significantly greater than each single mutant,
98
 suggesting that an exacerbated 
accumulation of regulatory RNA transcripts might contribute to the synthetic lethality of 
rrp47-∆ mpp6-∆ strains. 
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The mpp6-∆ mutation is also synthetic lethal with the rrp6-∆ mutation.98 This implies 
that Mpp6 and Rrp47 do not function in a functionally redundant manner to target 
substrates to Rrp6. It has been proposed that Mpp6 might promote the activity of the 
other exosome catalytic subunit, Rrp44.
98
 Given that human MPP6 protein physically 
interacts with PM-Scl100 and hMtr4,
14
 that it is associated with the exosome in the 
absence of Rrp44
105
 and that the yeast mpp6-∆ mutation shows strong genetic interactions 
with air1-∆ mutations,98, 109 another possibility is that Mpp6 promotes the functional 
coupling between Rrp6 and the TRAMP complex. 
 
Conclusion 
The recent discovery of diverse noncoding RNAs that are stabilised in the absence of 
Rrp6
55, 56, 110
 has dramatically increased the number of substrates known to be processed 
or degraded by the nuclear exosome. The molecular mechanisms by which the exosome 
is targeted to its substrate molecules and how RNA processing substrates are 
distinguished from those targeted to complete degradation, however, remain largely 
unresolved. These outstanding questions address fundamental issues concerning the links 
between transcription termination, RNA processing and RNP particle assembly, and the 
distinction between RNA processing events and RNA surveillance. A general point 
appears to be the redundancy seen for nucleolytic, polymerase and RNA-binding 
activities in exosome-mediated RNA 3’ processing that presumably facilitate efficient 
processing and provide a system that is well buffered against genetic modulation. 
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Legends to Figures 
Figure 1.  Structure of Rrp6. 
The top diagram illustrates the polypeptide structure of Rrp6.  The bottom panels 
compare the crystal structures of E. coli RNaseD and a N-terminal and C-terminal 
truncated version of Rrp6 from S. cerevisiae.  The molecules in the panels were derived 
from the Protein Data Base using PyMol. 
 
Figure 2.  Substrate recognition and degradation by the nuclear exosome. 
The schematic depicts the general pathway of exosome recruitment and substrate 
digestion/processing by the nuclear exosome complex. The exosome is recruited to its 
RNA substrates (either polymerase-engaged transcription termination complexes or RNP 
particles with accessible 3’ ends) through a poorly understood set of interactions that, in 
most cases, will involve both RNA binding with undetermined sequences or structures 
and protein recognition with poorly characterised partner proteins (labelled “X”). The 
DNA binding activity of Rrp47 may also promote recruitment of the exosome to 
termination regions. Degradation/processing of the RNA can be promoted by Trf4- or 
Trf5-mediated oligoadenylation and by the RNA helicase activity of Mtr4, all of which 
are components of the TRAMP complex, while Rrp47, Mpp6 and the Air proteins 
contribute to RNA binding. RNA hydrolysis by the Rrp6 and Rrp44 exonucleases 
progresses until enzyme activity is blocked by the preassembled RNP particle, allowing 
3’ end maturation. In the absence of correct RNP particle assembly, the RNA is degraded 
completely by the exosome and TRAMP complexes. Other substrates are generated by 
endonucleolytic cleavage or arise through delayed transcription/processing events. For 
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some substrates, Rrp6 can function together with Rrp47 and TRAMP, independently of 
the core exosome complex. 
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